DOI: https://dx.doi.org/10.18203/2349-3291.ijcp20220085
Published: 2022-01-24

Assessment of thyroid function status in transfusion dependent thalassemic children

Abul Basher M. Osman Hayder Mazumder, Suraiya Begum, Roksana Parvin, Salma Akter, Sumya Afrin Shanta

Abstract


Background: Frequent blood transfusions have been associated with serum iron overload, which may result in hypothyroidism and other endocrine abnormalities in transfusion dependent thalassemic patients. Thyroid dysfunction has been reported in a number of studies on these pts. The aim of the study is to assess the thyroid function status among the transfusion dependent thalassemic children.

Methods: This was a cross sectional study conducted in the department of transfusion medicine, department of Pediatric hematology and oncology and department of hematology, Bangabandhu Sheikh Mujib medical university (BSMMU), Dhaka for a period of 18 months. A total number of 86 children with transfusion dependent thalassemia who met the inclusion and exclusion criteria were studied. Demographic data as well as history of blood transfusion and chelation therapy were collected. Thyroid function and iron load status were evaluated by measuring serum FT4, TSH and ferritin levels.

Results: Out of 86 thalassemia patients, euthyroid patients were 77 (89.5%) and hypothyroid patients were 9 (10.5%). Eight (9.3%) patients were compensated and 1 (1.2%) was uncompensated hypothyroidism. Statistically significant association was found between number of blood transfusion and serum ferritin level (≥2000 ng/ml) with development of hypothyroidism in thalassemic patients. Mean ferritin level was higher in hypothyroid (4797.8±2027.4 ng/ml) group than in euthyroid (3628.8±2448.5 ng/ml) groups.

Conclusions: Frequency of hypothyroidism was 10.5% (compensated 9.3% and uncompensated 1.2%). Number of blood transfusion and ferritin level were found significantly associated with the development of hypothyroidism in thalassemic patients.


Keywords


Thyroid function, Transfusion dependent, Thalassemia

Full Text:

PDF

References


Jehanzeb K, Ahmad F, Lodhi MA, Ali S. Assessment of status of thyroid functions in patients of β thalassemia major, reporting to OPD of military hospital, Rawalpindi. Pak Armed Forces Med J. 2016;66(6):809-13.

Cappellini M, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A. Guidelines for the Clinical Management of Thalassaemia. Thalassaemia International Federation. 2008. Available at https://pubmed.ncbi.nlm.nih.gov/24308075/. Accessed 8 July 2021.

Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010;115(22):4331-6.

Khan WA, Banu B, Amin SK, Selimuzzaman M, Rahman M, Hossain B et al. Prevalence of beta thalassemia trait and Hb E trait in Bangladeshi school children and health burden of thalassemia in our population. DS (Child) HJ. 2005;21(1):17.

Lee G, Magro S, Puzzonia P, Consarino C, Galati MC, Morgione S et al. Hypothyroidism in patients with thalassemia syndromes. Acta haematologica. 1990;84(2):72-6.

Satwani H. Endocrinal complications in thalassemia: frequency and association with ferritin levels. Pak Red J. 2005;29:113-9.

Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR. Complications of β-thalassemia major in North America. Blood. 2004;104(1):34-9.

Borgna-Pignatti C, Rugolotto SP, Zhao H, Cappellini MD. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187-93.

Farmaki K, Tzoumari I, Pappa C, Chouliaras G, Berdoukas V. Normalization of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassemia major. Bri J haematol. 2010;148(3):466-75.

Thuret, I, Pondarré C, Loundou A, Steschenko D, Girot R, Bachir D et al. Complications and treatment of patients with β-thalassemia in France: results of the National Registry. Haematologica. 2010;95(5):724-9.

Eshragi P, Tamaddoni A, Zarifi K, Mohammad HA, Aminzadeh M. Thyroid function in major thalassemia patients: Is it related to height and chelation therapy? Casp J Internal Med. 2011;2(1):189.

Jaruratanasirikul S, Wongcharnchailert M, Laosombat V, Sangsupavanich P, Leetanaporn, K. Thyroid function in beta-thalassemic children receiving hypertransfusions with suboptimal iron-chelating therapy. J Med Association Thai. 2007;90(9):1798.

Pirinççioğlu AG, Deniz T, Gökalp D, Beyazit N, Haspolat K, Söker M. Assessment of thyroid function in children aged 1-13 years with Beta-thalassemia major. Iran J Pediatr. 2011;21(1):77.

Jaipuria R, Nigam RK, Malik R, Shrivastava A, Balani S, Tripathi A. Assessment of thyroid function in children with beta-thalassemia major and its correlation with serum ferritin and transfusion index. J Evolution Med Dental Sci. 2014;3(4):847-54.

Karim AR, Islam MR, Deeba F, Fakir MHJ. Matin A. Correlation of Thyroid Hormone Derangement with Serum Ferritin Level in Children with Beta Thalassaemia Major at a Tertiary Care Hospital of Bangladesh. J Shaheed Suhrawardy Med College. 2013;5(2):87-90.

Jain BB, Roy RN, Ghosh S, Ghosh T, Banergee U, Bhattacharya SK. Screening for thalassemia and other hemo-globinopathies in a tertiary care hospital of West Bengal: implications for population screening. Indian J Public Health. 2012;56:297-300.

Tahura S, Selimuzzaman M, Khan WA. Thalassaemia Prevention: Bangladesh Perspective-A Current Update. Bangla J Child Health. 2016;40(1):31-8.

Al-Kloub MI, Abed MA, Al Khawaldeh OA, Al Tawarah YM, Froelicher ES. Predictors of non-adherence to follow-up visits and deferasirox chelation therapy among Jordanian adolescents with Thalassemia major. Pediatric Hematol Oncol. 2014;31(7):624-37.

Kurtoglu AU, Kurtoglu E, Temizkan AK. Effect of iron overload on endocrinopathies in patients with beta-thalassaemia major and intermedia. Endokrynologia Polska. 2012;63(4):260-63.

Somchit J, Malai W, Vichai L, Pasuree S, Kalaya L. Thyroid function in beta thalassemic children receiving hypertransfusions with suboptimal iron chelating therapy. J Med Assoc Thai. 2007;90(9):1798.

Sharmin T, Mollah AH, Morshed AA, Chowdhury MK. Thyroid Status in Children with Transfusion Dependent Hb-E β-Thalassaemia. Mymensingh Med J. 2018;27(2):348-57.

Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N, Habibzadeh M et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocrine Dis. 2003;3(1):4.

Malik SA, Syed S, Ahmed N. Frequency of hypothyroidism in patients of b-thalassemia. J Pak Med Assoc. 2010; 60:17-21.

Zervas A, Katopodi A, Protonotariou A, Livadas S, Karagiorga M, Politis C et al. Assessment of thyroid function in two hundred patients with β-thalassemia major. Thyroid. 2002;12(2):151-4.

Agarwal MB, Shah S, Vishwanathan C, Rajadhyaksha G, Bhave AA, Dube SR et al. Thyroid dysfunction in multi-transfused iron loaded thalassemia patients. Indian Pediatr. 1992;29(8):997-102.

Gathwala G, Das K, Agrawal N. Thyroid hormone profile in beta-thalassemia major children. Bangladesh Med Res Council Bull. 2009;35(2):71-2.